tiprankstipranks
Trending News
More News >
Maravai Lifesciences Holdings, Inc. (MRVI)
:MRVI
US Market

Maravai Lifesciences Holdings (MRVI) Income Statement

Compare
411 Followers

Maravai Lifesciences Holdings Income Statement

Last quarter (Q3 2025), Maravai Lifesciences Holdings's total revenue was $41.63M, a decrease of -36.15% from the same quarter last year. In Q3, Maravai Lifesciences Holdings's net income was $-25.56M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 259.19M$ 288.94M$ 883.00M$ 799.24M$ 284.10M
Gross Profit
$ 108.31M$ 140.20M$ 714.04M$ 658.68M$ 204.45M
Operating Expenses
$ 343.93M$ 171.85M$ 139.83M$ 104.03M$ 84.55M
Depreciation and Amortization
$ 56.87M$ 48.78M$ 38.10M$ 24.75M$ 25.84M
EBITDA
$ -156.92M$ 712.41M$ 609.99M$ 585.78M$ 138.27M
Operating Income
$ -235.62M$ -31.65M$ 574.22M$ 554.64M$ 119.90M
Other Income/Expenses
$ -25.86M$ 649.38M$ -22.74M$ -23.88M$ -38.21M
Pretax Income
$ -261.48M$ 617.74M$ 551.47M$ 530.76M$ 81.70M
Net Income
$ -144.85M$ -119.03M$ 220.21M$ 182.04M$ 76.89M
Per Share Metrics
Basic EPS
$ -1.05$ -0.90$ 1.67$ 1.59$ 7.43
Diluted EPS
$ -1.05$ -0.90$ 1.67$ 1.56$ 2.36
Weighted Average Shares Outstanding
137.91M 131.92M 131.54M 114.79M 96.65M
Weighted Average Shares Outstanding (Diluted)
137.91M 131.92M 131.69M 121.97M 96.65M
Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History